Cargando…
CYP4F2 polymorphism as a genetic risk factor for major hemorrhagic complications in Chinese patients on warfarin therapy
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Science Press
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3418912/ https://www.ncbi.nlm.nih.gov/pubmed/23097648 http://dx.doi.org/10.3724/SP.J.1263.2012.04162 |
_version_ | 1782240670541414400 |
---|---|
author | Wang, Hong-Juan Ma, Cong Yang, Jie Xu, Qiang Zhang, Yan Gao, Lei Xu, Bin Zhang, Yu-Xiao Li, Yang Yin, Tong |
author_facet | Wang, Hong-Juan Ma, Cong Yang, Jie Xu, Qiang Zhang, Yan Gao, Lei Xu, Bin Zhang, Yu-Xiao Li, Yang Yin, Tong |
author_sort | Wang, Hong-Juan |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-3418912 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2012 |
publisher | Science Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-34189122012-10-24 CYP4F2 polymorphism as a genetic risk factor for major hemorrhagic complications in Chinese patients on warfarin therapy Wang, Hong-Juan Ma, Cong Yang, Jie Xu, Qiang Zhang, Yan Gao, Lei Xu, Bin Zhang, Yu-Xiao Li, Yang Yin, Tong J Geriatr Cardiol Letters to the Editor Science Press 2012-06 /pmc/articles/PMC3418912/ /pubmed/23097648 http://dx.doi.org/10.3724/SP.J.1263.2012.04162 Text en Institute of Geriatric Cardiology http://creativecommons.org/licenses/by-nc-sa/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 Unported License, which allows readers to alter, transform, or build upon the article and then distribute the resulting work under the same or similar license to this one. The work must be attributed back to the original author and commercial use is not permitted without specific permission. |
spellingShingle | Letters to the Editor Wang, Hong-Juan Ma, Cong Yang, Jie Xu, Qiang Zhang, Yan Gao, Lei Xu, Bin Zhang, Yu-Xiao Li, Yang Yin, Tong CYP4F2 polymorphism as a genetic risk factor for major hemorrhagic complications in Chinese patients on warfarin therapy |
title | CYP4F2 polymorphism as a genetic risk factor for major hemorrhagic complications in Chinese patients on warfarin therapy |
title_full | CYP4F2 polymorphism as a genetic risk factor for major hemorrhagic complications in Chinese patients on warfarin therapy |
title_fullStr | CYP4F2 polymorphism as a genetic risk factor for major hemorrhagic complications in Chinese patients on warfarin therapy |
title_full_unstemmed | CYP4F2 polymorphism as a genetic risk factor for major hemorrhagic complications in Chinese patients on warfarin therapy |
title_short | CYP4F2 polymorphism as a genetic risk factor for major hemorrhagic complications in Chinese patients on warfarin therapy |
title_sort | cyp4f2 polymorphism as a genetic risk factor for major hemorrhagic complications in chinese patients on warfarin therapy |
topic | Letters to the Editor |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3418912/ https://www.ncbi.nlm.nih.gov/pubmed/23097648 http://dx.doi.org/10.3724/SP.J.1263.2012.04162 |
work_keys_str_mv | AT wanghongjuan cyp4f2polymorphismasageneticriskfactorformajorhemorrhagiccomplicationsinchinesepatientsonwarfarintherapy AT macong cyp4f2polymorphismasageneticriskfactorformajorhemorrhagiccomplicationsinchinesepatientsonwarfarintherapy AT yangjie cyp4f2polymorphismasageneticriskfactorformajorhemorrhagiccomplicationsinchinesepatientsonwarfarintherapy AT xuqiang cyp4f2polymorphismasageneticriskfactorformajorhemorrhagiccomplicationsinchinesepatientsonwarfarintherapy AT zhangyan cyp4f2polymorphismasageneticriskfactorformajorhemorrhagiccomplicationsinchinesepatientsonwarfarintherapy AT gaolei cyp4f2polymorphismasageneticriskfactorformajorhemorrhagiccomplicationsinchinesepatientsonwarfarintherapy AT xubin cyp4f2polymorphismasageneticriskfactorformajorhemorrhagiccomplicationsinchinesepatientsonwarfarintherapy AT zhangyuxiao cyp4f2polymorphismasageneticriskfactorformajorhemorrhagiccomplicationsinchinesepatientsonwarfarintherapy AT liyang cyp4f2polymorphismasageneticriskfactorformajorhemorrhagiccomplicationsinchinesepatientsonwarfarintherapy AT yintong cyp4f2polymorphismasageneticriskfactorformajorhemorrhagiccomplicationsinchinesepatientsonwarfarintherapy |